Integral Ad Science (NASDAQ:IAS) Trading Down 2.3%

Integral Ad Science Holding Corp. (NASDAQ:IAS - Get Free Report)'s stock price dropped 2.3% on Tuesday . The company traded as low as $9.44 and last traded at $9.49. Approximately 394,843 shares were traded during trading, a decline of 79% from the average daily volume of 1,848,740 shares. The stock had previously closed at $9.71.

Analysts Set New Price Targets

IAS has been the subject of a number of recent research reports. BMO Capital Markets decreased their price target on shares of Integral Ad Science from $18.00 to $16.00 and set an "outperform" rating for the company in a research note on Wednesday, February 28th. Piper Sandler decreased their price target on shares of Integral Ad Science from $20.00 to $18.00 and set an "overweight" rating for the company in a research note on Wednesday, February 28th. Loop Capital started coverage on shares of Integral Ad Science in a research note on Tuesday, April 30th. They set a "buy" rating and a $15.00 price target for the company. Morgan Stanley restated an "equal weight" rating and set a $12.00 price objective (down previously from $18.00) on shares of Integral Ad Science in a research report on Tuesday, April 16th. Finally, Benchmark restated a "hold" rating on shares of Integral Ad Science in a research report on Tuesday, May 7th. Three equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, Integral Ad Science presently has a consensus rating of "Moderate Buy" and an average target price of $16.77.

Integral Ad Science Price Performance

The company's 50-day moving average is $9.61 and its 200-day moving average is $12.76. The company has a debt-to-equity ratio of 0.13, a current ratio of 4.32 and a quick ratio of 4.32. The firm has a market capitalization of $1.52 billion, a price-to-earnings ratio of 971.97, a PEG ratio of 1.50 and a beta of 1.58.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last announced its quarterly earnings results on Thursday, May 9th. The company reported ($0.01) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.01). The firm had revenue of $114.50 million for the quarter, compared to analysts' expectations of $112.12 million. Integral Ad Science had a net margin of 0.59% and a return on equity of 0.32%. Integral Ad Science's revenue was up 7.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.02 earnings per share. On average, research analysts expect that Integral Ad Science Holding Corp. will post 0.18 earnings per share for the current year.

Insider Buying and Selling at Integral Ad Science

In other news, CAO Alexis Gil II sold 3,177 shares of Integral Ad Science stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $10.24, for a total transaction of $32,532.48. Following the sale, the chief accounting officer now owns 120,195 shares in the company, valued at $1,230,796.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CFO Tania Secor sold 8,929 shares of Integral Ad Science stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $9.71, for a total transaction of $86,700.59. Following the sale, the chief financial officer now owns 221,959 shares in the company, valued at $2,155,221.89. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Alexis Gil II sold 3,177 shares of Integral Ad Science stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $10.24, for a total transaction of $32,532.48. Following the sale, the chief accounting officer now owns 120,195 shares in the company, valued at approximately $1,230,796.80. The disclosure for this sale can be found here. Insiders have sold a total of 75,126 shares of company stock valued at $749,707 over the last ninety days. Corporate insiders own 2.00% of the company's stock.

Institutional Trading of Integral Ad Science

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Skandinaviska Enskilda Banken AB publ bought a new stake in shares of Integral Ad Science in the third quarter worth $58,000. DekaBank Deutsche Girozentrale acquired a new position in Integral Ad Science in the third quarter worth $62,000. Ameritas Investment Partners Inc. boosted its holdings in Integral Ad Science by 40.1% in the first quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company's stock worth $67,000 after purchasing an additional 1,924 shares during the period. Amalgamated Bank boosted its holdings in Integral Ad Science by 19.9% in the third quarter. Amalgamated Bank now owns 6,951 shares of the company's stock worth $83,000 after purchasing an additional 1,156 shares during the period. Finally, Sherbrooke Park Advisers LLC acquired a new position in Integral Ad Science in the third quarter worth $140,000. Institutional investors own 95.78% of the company's stock.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.